Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06443359 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06443359 · ClinicalTrials.gov record · last posted 2026-04-20

Hypofractionated Regional Nodal Irradiation in Breast Cancer

StatusActive, Not Recruiting
PhaseNot applicable
Started2018-11-13
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
This is a prospective clinical trial designed to evaluate the efficacy and safety of hypofractionated regional nodal irradiation in breast cancer patients. After enrollment, participants will be stratified into 2 Groups based on the extent of axillary surgery. Participants will complete activities and assessments at baseline, and after completion of treatment at 1-2 weeks, 3 months, 6 months, 1 year, 2 year, and 3 years following completion of treatment.

Amendment record 3 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 3 times since 2024-05-30; most recent amendment 2026-04-15. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2025-03-11
Status change Recruiting→Active, Not Recruitingv1
Trial Details
NCT Number NCT06443359
Lead Sponsor Corewell Health East
Conditions Breast Cancer
Enrollment 56 participants
Start Date 2018-11-13
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-04-20